Nuclear Medicine: Page 37

IBA reports revenue rebound in 2020

By AuntMinnie.com staff writers

Proton therapy developer Ion Beam Applications (IBA) bounced back with growth of 10.4% in revenues in 2020 after reporting reduced revenues for the first half of the year due to challenges presented by the COVID-19 pandemic.

March 24, 2021

Novartis touts phase III prostate cancer study results

By AuntMinnie.com staff writers

Novartis is highlighting results from a phase III study that has investigated the efficacy and safety of Lu-177 PSMA-617, a radioligand therapy for patients with prostate-specific membrane antigen-positive metastatic prostate cancer.

March 22, 2021

New radiotracer for neuroendocrine tumors appears safe

By Will Morton

A new radiopharmaceutical based on lutetium-177 being tested for the treatment of neuroendocrine tumors is safe and effective and may allow physicians to cut the radiation dose patients receive by half, according to a study published online March 19 in the Journal of Nuclear Medicine.

March 22, 2021

Novel radiotracer shows promise for prostate imaging

By Will Morton

An experimental new radiotracer is effective when used with PET/CT for detecting biochemically recurrent prostate cancer and may change patient management, according to research published online March 12 in the Journal of Nuclear Medicine.

March 21, 2021

Mich. cardiologist pays $2M to settle billing case

By AuntMinnie.com staff writers

A Michigan cardiologist and his practice paid the U.S. government $2 million to resolve allegations they violated the False Claims Act by knowingly billing federal healthcare programs for diagnostic testing that was either unnecessary or not performed.

March 18, 2021

BWXT, GMS form joint venture for Asia-Pacific

By AuntMinnie.com staff writers

BWX Technologies (BWXT) subsidiary and medical isotope and radiopharmaceutical supplier BWXT Medical has formed a joint venture for the Asia-Pacific region with nuclear medicine and radiopharmacy firm Global Medical Solutions (GMS).

March 8, 2021

NorthStar, IBA expand Tc-99m collaboration

By AuntMinnie.com staff writers

NorthStar Medical Radioisotopes and proton therapy developer Ion Beam Applications (IBA) are expanding their collaboration in an effort to increase the supply of technetium-99m (Tc-99m) around the world.

March 7, 2021

Navidea signs deal for $5M in preferred shares

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals has signed an agreement with the company's largest shareholder for a private placement of up to $5 million in preferred stock.

March 4, 2021

NorthStar reorganizes to advance nuclear medicine agents

By AuntMinnie.com staff writers

NorthStar Medical Radioisotopes has appointed its executive Dave Wilson to a new position as part of a reorganization it says will boost availability of molybdenum-99 in the U.S. and advance development of other radioisotopes.

March 3, 2021

Q BioMed wins Strontium89 supply deal for DOD, VA

By AuntMinnie.com staff writers

Biotech company Q BioMed has landed a contract to supply its Strontium89 metastatic bone cancer palliation radiopharmaceutical to the U.S. Department of Defense (DOD) and the Department of Veterans Affairs (VA).

March 1, 2021

Lantheus experiences net loss in Q4, full fiscal year

By AuntMinnie.com staff writers

A slight increase in revenue for the fourth quarter wasn't enough to offset a net loss for Lantheus Holdings, parent company of Lantheus Medical Imaging, in either the fourth quarter or for the full year.

February 25, 2021

RadQual signs distribution deal with LEA

By AuntMinnie.com staff writers

Radioisotope manufacturer International Isotope's RadQual nuclear medicine quality-control subsidiary has signed a North American licensing agreement with French calibration equipment provider Laboratoire d'Etalons d'Activite (LEA).

February 8, 2021

Previous Page

Page 37 of 438

Next Page